Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
Nascent Biotech established in 2019 with an aim to revolutionize and catalyze high-impact biotechnologies and products, has continually pushed boundaries in its pursuit of groundbreaking innovations. It prides itself on highly engaged customer service, attention to detail and quality control, creating lasting customer relationships and delivering unparalleled scientific solutions.
Our mission is to become a market leader in biotechnologies by consistently developing, manufacturing, and delivering high-quality and cost-effective products for research and clinical applications.
Our vision is to become a symbol of excellence in the future of biotechnologies by striving to continuously push boundaries to make life easier, healthier and more enjoyable.
